Udayavni Special

No plans to get into vaccine production as it requires separate manufacturing infra: Sun Pharma


PTI, Jun 13, 2021, 1:04 PM IST

New Delhi: Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different manufacturing set-up, as per a top company official.

The Mumbai-based company, which is strong in various generic therapeutic segments, is eyeing biosimilars to fuel its future growth.

“I think our preliminary assessment indicates that vaccines will require a dedicated manufacturing facility and it cannot be produced in a facility where we are making multiple other products,” Sun Pharmaceutical Industries Managing Director Dilip Shanghvi said in a call with analysts.

The billionaire industrialist noted that for getting into vaccine production, a completely new set of manufacturing infrastructure is required.

“So, that”s broadly our understanding. So, we currently don”t have any facility which we are looking at for producing vaccines,” Shanghvi said.

On the biosimilar front, he noted that the drug firm is looking to develop a range of such products.

“We are evaluating development of some biosimilars which can be classified amongst the third wave of biosimilars,” Shanghvi said while clarifying that the company is looking at 2030 kind of timeline for such products to hit the market.

A biosimilar is a product which is similar to another already approved biological medicine.

The company is looking at products which have significant future patent expiry dates so that it could be amongst the first firms to get initial approvals, Shanghvi said.

“That”s the focus and priority. And that”s not the only (thing), there are multiple priorities, and also (we are) trying to find a way by which we can leverage our presence in the market so that we can successfully build a biosimilars portfolio,” he added.

He noted that the development of the biosimilars would not be a ”big drain” on the company’s cash flow and profitability.

Commenting on the US business, he said the drug firm’s current generic pipeline for the US market includes 94 abbreviated new drug applications (ANDAs) and nine new drug applications (NDAs) awaiting approval with the US FDA.

In 2020-21, the company launched around 18 new products in the US.

On business outlook, Shanghvi noted: “Given the uncertainties of the pandemic in the near term, we are refraining from giving guidance for FY22. However, all our businesses are well positioned and our endeavour will be to grow the business, notwithstanding the near term uncertainties related to COVID-19.”

The drug firm’s revenue from operations stood at Rs 33,498 crore in 2020-21.

Commenting on the company’s Halol plant, which has been under the USFDA radar for the last few years, Shanghvi said the drug firm is waiting for the regulator to inspect the facility.

“We have requested for an inspection. Now, I think it’s up to them to inspect the facility. And hopefully this time we should be able to clear it successfully, that”s the focus,” he added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

HDFC bank’s ad saying ‘2021 batch students not eligible’ faces outrage on internet

K’taka Cabinet: Swearing-in ceremony of newly inducted ministers begins

SBI net profit in Q1 surges 55 pc to Rs 6,504 crore

Kerala govt relaxes lockdown curbs; shops to open 6 days

COVID-19 herd immunity? It’s not going to happen, so what next?

PM Modi dials Mamata, assures her of all help to mitigate flood situation in Bengal

Kejriwal announces magisterial probe into death of Dalit girl, Rs 10 lakh compensation for family


Related Articles More

A dog made ferocious by circumstances; a myth that stray dogs are dangerous by nature: Kerala HC

Kerala govt relaxes lockdown curbs; shops to open 6 days

PM Modi dials Mamata, assures her of all help to mitigate flood situation in Bengal

Kejriwal announces magisterial probe into death of Dalit girl, Rs 10 lakh compensation for family

IAF chief in Israel to discuss enhancement of bilateral military ties

MUST WATCH

INSIGHTS ON ONLINE JOB SCAMS

COMEDY KHILADIGALU RAKESH POOJARY Special Interview part 2

Molested, Guwahati woman drags man riding scooter into drain

Aravind bella fans pray

Shridhar Bhat | Man who carried the deity in processions more than 1,000 times

Latest Additions

HDFC bank’s ad saying ‘2021 batch students not eligible’ faces outrage on internet

A dog made ferocious by circumstances; a myth that stray dogs are dangerous by nature: Kerala HC

K’taka Cabinet: Swearing-in ceremony of newly inducted ministers begins

Udupi: Woman cheated of lakhs by man who befriended her on FB

SBI net profit in Q1 surges 55 pc to Rs 6,504 crore

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.